ICL study finds single bowel screening test can reduce chances of developing cancer
Affecting over 250,000 people, bowel cancer is the fourth most common cancer in the UK
Read More
Author: Jen Brogan
Study reveals two proteins that may contribute to stroke recurrence or other MACEs
The life-threatening medical condition affects 100,000 people in the UK every year
Read More
MJFF awards $6m to Lario Therapeutics for Parkinson’s research
The neurological disease is estimated to affect more than ten million people globally
Read More
Trial investigates faecal microbiota transplantation to treat rare liver disease
Primary sclerosing cholangitis is estimated to affect one in 100,000 people worldwide annually
Read More
New study shows wearable trackers provide clinical use for heart disease patients
Cardiovascular disease, including coronary heart disease, currently affects around seven million people in the UK
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
